Приказ основних података о документу
Origanum heracleoticum L. and Origanum vulgare L. seeds germination stimulators
Stimulatori klijavosti semena Origanum heracleoticum L. i Origanum vulgare L.
dc.creator | Filipović, Vladimir | |
dc.creator | Popović, Vera | |
dc.creator | Aćimović, Milica | |
dc.creator | Marković, Tatjana | |
dc.creator | Protić, Rade | |
dc.creator | Ugrenović, Vladan | |
dc.creator | Sikora, Vladimir | |
dc.date.accessioned | 2021-04-26T19:13:46Z | |
dc.date.available | 2021-04-26T19:13:46Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0455-6224 | |
dc.identifier.uri | http://fiver.ifvcns.rs/handle/123456789/1371 | |
dc.description.abstract | This paper studies the effect of gibberellic acid (GA3), herbal preparation (LAB1) and the pre-cooling treatment (Ph) on seed germination of Origanum heracleoticum L.and Origanum vulgare L. As a control variant, seed treatment with distilled water was used. The highest germination energy (EK), germination after 14 days (14D) and a total germination values (UK) were achieved with seeds of O. heracleoticum treated with 400ppm GA3 (50.3%, 57.3% and 64.8%, respectively) and the lowest values were observed with 3-day pre-cooling treatment (28.3%, 28.8% and 28.8%, respectively). The highest values for all seed quality parameters for O. vulgare were achieved by the treatment with the highest GA3 concentration, 1000 ppm (60.0%, 67.0% and 74.8%, respectively), while the lowest germination values were recorded in 4-day pre-cooling treatment (26.0%, 26.8% and 27.5%, respectively). Overall, higher germination was observed in seeds of O. vulgare. The best germination stimulitor for both species proved to be gibberellic acid (GA3) - a hormone of plant origin, followed by the herbal preparation (LAB1), then the control variant (DW). On the other hand, the most unfavourable to stimulate germination proved to be pre-cooling treatment (Ph), which had no impact on the increase of seeds germination. | en |
dc.description.abstract | U radu je ispitivan uticaj giberelinske kiseline (GA3), pripravka od lekovitog bilja (LAB1) i prethodnog hlađenja (Ph) na klijavost semena vrsta Origanum heracleoticum L. i Origanum vulgare L. Kao kontrolna varijanta, korišćen je tretman semena destilovanom vodom (DW). Najveća energija klijanja (EK), klijavost nakon 14 dana (14D) i ukupna klijavost (UK) vrste O. heracleoticum ostvarene su kod semena tretiranog sa 400 ppm GA3 (50,3%, 57,3%, odnosno 64,8%), a najmanje vrednosti istih parametara su zabeležene pri tretmanu sa trodnevnim prethodnim hlađenjem (28,3%, 28,8%, odnosno 28,8%). Najveće vrednosti za sve ispitivane parametre kvaliteta semena vrste O. vulgare ostvarene su pri najvećoj GA3 koncentraciji od 1000 ppm (60,0%, 67,0%, odnosno 74,8%), dok su najmanje vrednosti kodove biljne vrste zabeležene pri tretmanu semena prethodnim četvorodnevnim hlađenjem (26,0%, 26,8% i 27,5%). Ukupno gledano, veću klijavost imalo je seme vrste O. vulgare. | sr |
dc.publisher | Institut za proučavanje lekovitog bilja Dr Josif Pančić, Beograd | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/46006/RS// | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Lekovite sirovine | |
dc.subject | Origanum vulgare | en |
dc.subject | Origanum heracleoticum | en |
dc.subject | GA3 | en |
dc.subject | herbal preparation | en |
dc.subject | precooling treatment | en |
dc.subject | parameters of seed quality | en |
dc.subject | Origanum vulgare | sr |
dc.subject | Origanum heracleoticum | sr |
dc.subject | GA3 | sr |
dc.subject | pripravak od lekovitog bilja | sr |
dc.subject | tretman prethodnim hlađenjem | sr |
dc.subject | parametri kvaliteta semena | sr |
dc.title | Origanum heracleoticum L. and Origanum vulgare L. seeds germination stimulators | en |
dc.title | Stimulatori klijavosti semena Origanum heracleoticum L. i Origanum vulgare L. | sr |
dc.type | article | |
dc.rights.license | BY | |
dc.citation.epage | 91 | |
dc.citation.issue | 34 | |
dc.citation.other | 34(34): 81-91 | |
dc.citation.rank | M52 | |
dc.citation.spage | 81 | |
dc.citation.volume | 34 | |
dc.identifier.doi | 10.5937/leksir1434081F | |
dc.identifier.fulltext | http://fiver.ifvcns.rs/bitstream/id/313/1368.pdf | |
dc.type.version | publishedVersion |